[Oral pristinamycin therapy for bone and joint infections in children. A report of 50 cases (author's transl)].
50 children with bone and joint infections (acute osteomyelitis, suppurative acute arthritis, osteoarthritis) were treated with pristinamycin. The responsible bacterium was most often but not exclusively Staphylococcus aureus; its sensitivity to various antibiotics is discussed. The value of biochemical tests for diagnosis and follow-up is emphasized; the potency of this drug avoids the need for intravenous therapy. A therapeutic protocol according to age, type of and sensitivity of the germs is proposed.
D000293:Adolescent; D001170:Arthritis, Infectious / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D005260:Female; D005839:Gentamicins / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D010000:Osteitis / Q000188:drug therapy*; D010003:Osteoarthritis / Q000188:drug therapy*; D010019:Osteomyelitis / Q000188:drug therapy*; D011379:Prognosis; D013997:Time Factors; D014769:Virginiamycin / Q000627:therapeutic use*
D005839:Gentamicins; D014769:Virginiamycin
Traitement des infections osseuses et articulaires de l'enfant par la pristinamycine. A propos de 50 cas.